Literature DB >> 16185876

Antiproliferative properties of piperidinylchalcones.

Xiaoling Liu1, Mei-Lin Go.   

Abstract

Methoxylated chalcones bearing N-methylpiperidinyl substituents on ring A inhibited the growth of human tumour cell lines (MCF, HCT 116, and Jurkat) at IC50 values of <5 microM. Investigations on a representative member (12) showed that antiproliferative activity was linked to the disruption of the cell cycle at G1 and G2/M phases. The effect was concentration dependent and was evident at the approximate IC50 of 12. Down regulation of cell cycle regulatory components (CDK4, cyclin B, E2F, and phosphorylated Rb) were observed under similar conditions. Methoxylated chalcones without the piperidinyl substituent were found to exert equally potent and selective antiproliferative activity against HCT 116 tumour cells but did not interfere with cell cycle progression at their IC50 concentrations. The presence of the piperidinyl substituent in the chalcone template is proposed to lend specificity to the mechanism of antiproliferative activity, in addition to promoting a more desirable physicochemical profile.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185876     DOI: 10.1016/j.bmc.2005.08.006

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  Dietary chalcones with chemopreventive and chemotherapeutic potential.

Authors:  Barbora Orlikova; Deniz Tasdemir; Frantisek Golais; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2011-02-04       Impact factor: 5.523

2.  Structural Optimization of Indole Derivatives Acting at Colchicine Binding Site as Potential Anticancer Agents.

Authors:  Dong-Jin Hwang; Jin Wang; Wei Li; Duane D Miller
Journal:  ACS Med Chem Lett       Date:  2015-08-06       Impact factor: 4.345

3.  (E)-4-aryl-4-oxo-2-butenoic acid amides, chalcone-aroylacrylic acid chimeras: design, antiproliferative activity and inhibition of tubulin polymerization.

Authors:  Maja D Vitorović-Todorović; Aleksandra Erić-Nikolić; Branka Kolundžija; Ernest Hamel; Slavica Ristić; Ivan O Juranić; Branko J Drakulić
Journal:  Eur J Med Chem       Date:  2013-01-11       Impact factor: 6.514

4.  Hybrid alpha-bromoacryloylamido chalcones. Design, synthesis and biological evaluation.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Dora Carrion; Olga Cruz-Lopez; Carlota Lopez Cara; Jan Balzarini; Ernest Hamel; Alessandro Canella; Enrica Fabbri; Roberto Gambari; Giuseppe Basso; Giampietro Viola
Journal:  Bioorg Med Chem Lett       Date:  2009-02-12       Impact factor: 2.823

5.  Design, synthesis, and biological evaluation of stable colchicine binding site tubulin inhibitors as potential anticancer agents.

Authors:  Yan Lu; Jianjun Chen; Jin Wang; Chien-Ming Li; Sunjoo Ahn; Christina M Barrett; James T Dalton; Wei Li; Duane D Miller
Journal:  J Med Chem       Date:  2014-08-26       Impact factor: 7.446

6.  Novel benzylidene benzofuranone analogues as potential anticancer agents: design, synthesis and in vitro evaluation based on CDK2 inhibition assays.

Authors:  Aravinda Pai; Jayashree B S
Journal:  3 Biotech       Date:  2022-09-02       Impact factor: 2.893

7.  Privileged Scaffold Chalcone: Synthesis, Characterization and Its Mechanistic Interaction Studies with BSA Employing Spectroscopic and Chemoinformatics Approaches.

Authors:  Nidhi Singh; Neeraj Kumar; Garima Rathee; Damini Sood; Aarushi Singh; Vartika Tomar; Sujata K Dass; Ramesh Chandra
Journal:  ACS Omega       Date:  2020-01-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.